advertisement

Meds and you

07 March 2014

US fears for patents on next-generation drugs in India

The US is concerned about Indian authorities considering allowing local firms to make new varieties of cheap generic drugs that are still on patent.

The United States has voiced concern over protection of patents on safer and more effective next-generation medicines in India, amid fears that authorities are considering allowing more Indian firms to make new varieties of cheap generic drugs still on patent.

Protecting next-generation drugs

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.